Brief: Genscript Biotech Sees An Adjusted Loss Of Us$290.4 Million To Us$316.2 Million For Year
Feb 18 (Reuters) - Genscript Biotech Corp 1548.HK :
* SEES AN ADJUSTED LOSS OF APPROXIMATELY US$290.4 MILLION TO
US$316.2 MILLION FOR YEAR
* SEES A LOSS OF APPROXIMATELY US$466.9 MILLION TO US$518.6
MILLION FOR YEAR
Source text for Eikon: ID:nHKS6mkVmq
Further company coverage: 1548.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale